source
- Legend Biotech CEO Ying Huang resigns, interim leader Alan Bash appointedLegend Biotech announced that its chief executive, Ying Huang, Ph.D., stepped down on Friday, with no permanent successor named yet. The board named Alan Bash as interim CEO on July 23, according…
- Genetic markers linked to Yescarta toxicity identified, opening path to safer CAR-T designsResearchers analyzed data from patients who received Kite Pharma's Yescarta CAR-T therapy in clinical trials. The analysis uncovered specific genetic signatures that correlate with higher risk of…